@misc{indiciae1616c10b8d99,
  title = {RBD-based high affinity ACE2 antagonist limits SARS-CoV-2 replication in upper and lower airways},
  author = {Gagne, M. and Flynn, B. J. and Honeycutt, C. C. and Flebbe, D. R. and Andrew, S. F. and Provost, S. J. and McCormick, L. and Van Ry, A. and McCarthy, E. and Todd, J.-P. M. and Bao, S. and Teng, I.-T. and Marciano, S. and Rudich, Y. and Li, C. and Pessaint, L. and Dodson, A. and Cook, A. and Lewis, M. G. and Andersen, H. and Zahradnik, J. and Nason, M. C. and Foulds, K. E. and Kwong, P. D. and Roederer, M. and Schreiber, G. and Seder, R. A. and Douek, D. C.},
  year = {2023},
  doi = {10.1101/2023.06.09.544432},
  url = {https://www.biorxiv.org/content/10.1101/2023.06.09.544432v1},
  note = {Source identifier: 10.1101/2023.06.09.544432}
}